Wells Fargo
MNPR icon

Wells Fargo’s Monopar Therapeutics MNPR Stock Holding History

Wells Fargo’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
3,958
+2,230
+129% +$138K ﹤0.01% 4826
2026
Q1 		$94.7K Sell
1,728
-3,397
-66% -$205K ﹤0.01% 5130
2025
Q4 		$335K Buy
5,125
+2,804
+121% +$229K ﹤0.01% 4764
2025
Q3 		$190K Buy
2,321
+20
+0.9% +$894 ﹤0.01% 4958
2025
Q2 		$82.3K Buy
2,301
+2,051
+820% +$74.5K ﹤0.01% 5307
2025
Q1 		$9.1K Hold
250
– – ﹤0.01% 5901
2024
Q4 		$5.5K Sell
250
-250
-50% -$4.2K ﹤0.01% 6046
2024
Q3 		$3.37K Hold
500
– – ﹤0.01% 5992
2024
Q2 		$1.82K Buy
500
+193
+63% +$679 ﹤0.01% 6029
2024
Q1 		$1.05K Buy
307
+300
+4,286% +$894 ﹤0.01% 6139
2023
Q4 		$13 Hold
7
– – ﹤0.01% 7329
2023
Q3 		$20 Hold
7
– – ﹤0.01% 7201
2023
Q2 		$28 Buy
7
+1
+17% +$5 ﹤0.01% 7212
2023
Q1 		$43 Hold
6
– – ﹤0.01% 7147
2022
Q4 		$73 Hold
6
– – ﹤0.01% 6882
2022
Q3 		$0 Hold
6
– – ﹤0.01% 7098
2022
Q2 		$0 Buy
6
+1
+20% +$11 ﹤0.01% 7228
2022
Q1 		$0 Hold
5
– – ﹤0.01% 7531
2021
Q4 		$0 Hold
5
– – ﹤0.01% 7591
2021
Q3 		$0 Hold
5
– – ﹤0.01% 7306
2021
Q2 		$0 Buy
5
+1
+25% +$29 ﹤0.01% 7229
2021
Q1 		$0 Hold
4
– – ﹤0.01% 7191
2020
Q4 		$0 Buy
4
+1
+33% +$26 ﹤0.01% 6807
2020
Q3 		$0 Buy
+3
New +$97 ﹤0.01% 6673

Other funds holding MNPR

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wells Fargo's MNPR Position: Q2 2026 in Review

Wells Fargo increased its Monopar Therapeutics (MNPR) stake by 129% in Q2 2026, buying an estimated $138K and bringing the position to 3,958 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #4826.

Wells Fargo first reported a position in MNPR in Q3 2020 and has held it in 24 quarters since. 96 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Wells Fargo held 3,958 shares of Monopar Therapeutics worth $366K as of Q2 2026.
  • Wells Fargo bought 2,230 Monopar Therapeutics shares in Q2 2026, an estimated $138K.
  • Monopar Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4826 holding.
  • Wells Fargo first reported a position in Monopar Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 96 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.